Samuel Agresta
Plus aucun poste en cours
Fortune : 1 $ au 31/01/2024
Historique de carrière de Samuel Agresta
Anciens postes connus de Samuel Agresta
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/09/2019 | 11/09/2023 |
| INFINITY PHARMACEUTICALS, INC. | Director/Board Member | 16/10/2019 | 24/07/2023 |
| Chief Tech/Sci/R&D Officer | 07/08/2018 | 16/10/2019 | |
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2011 | 01/08/2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2010 | 01/12/2011 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/11/2007 | 01/12/2010 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Corporate Officer/Principal | 01/08/2004 | 01/11/2010 |
Formation de Samuel Agresta
| University of South Florida | Graduate Degree |
| Georgetown University | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 11 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 5 |
| Graduate Degree | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
- Bourse
- Insiders
- Samuel Agresta
- Expérience
